Down-regulation of heat-shock protein 70 (HSP-70) correlated with responsiveness to neoadjuvant aromatase inhibitor therapy in breast cancer patients.

Yiu, Christopher C P

Down-regulation of heat-shock protein 70 (HSP-70) correlated with responsiveness to neoadjuvant aromatase inhibitor therapy in breast cancer patients. [electronic resource] - Anticancer research Sep 2010 - 3465-72 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1791-7530


Aged
Androstadienes--therapeutic use
Antineoplastic Agents--therapeutic use
Aromatase Inhibitors--therapeutic use
Breast Neoplasms--drug therapy
Down-Regulation
Drug Resistance, Neoplasm--physiology
Female
HSP70 Heat-Shock Proteins--biosynthesis
Humans
Immunohistochemistry
Ki-67 Antigen--biosynthesis
Letrozole
Neoadjuvant Therapy
Nitriles--therapeutic use
Randomized Controlled Trials as Topic
Triazoles--therapeutic use